In models of hyperlipidemia, pterostilbene increased expression of the lipid-lowering peroxisome proliferator-activated receptor γ [21], which in turn increased the expression of both PCSK9 and LDLR via SREBP2 processing [40]. The gene discussed is PCSK9; the disease is hyperlipidemia.